• Lead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programs. • Serve as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. • Build and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisions. • Partner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation priorities. • Own the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modeling. • Collaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptions. • Anticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisions. • Convert complex commercial analyses into clear, strategic recommendations for regional leadership teams. • Act as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readiness. • Lead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activities. • Oversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworks. • Ensure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regions. • Oversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advances. • Provide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plans. • Monitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoption.